March 29 (SeeNews) - Bulgarian pharmaceuticals trader Sopharma Trading [BUL:SFT] said its pre-tax profit went up 13% on the year to 8.47 million levs ($4.68 million/4.33 million euro) in the first two months of 2024.
The company's sales revenue grew by an annual 12% to some 234 million levs in January-February, Sopharma Trading said in a stock exchange filing on Thursday.
In February alone, Sopharma Trading's pre-tax profit came in at 4.36 million levs, up by 55% in annual terms, while its sales increased by 17% year-on-year to 114.1 million levs.
On a consolidated basis, the company's revenue climbed by a yearly 12% to 309.4 million levs in January-February, whereas its pre-tax profit leapt by 21% to 10.8 million levs.
The company is a unit of Bulgarian pharmaceuticals producer Sopharma [BUL:SFA]. Shares in Sopharma Trading last traded on Thursday when they closed at 5.75 levs on the Bulgarian Stock Exchange, bourse data show.
(1 euro = 1.95583 levs)